United States • Needlestick Safety and Prevention Act, effective date 2001 Two lawyers,
Mike Weiss and Paul Danzinger, were approached in 1998 by an inventor, Thomas Shaw, who was having trouble selling a safety syringe developed to protect health care workers from accidentally being infected by dirty needles. The problems were due to
monopolistic actions of a major industry needle maker and hospital group purchasing organizations. The case was settled before trial for $150 million. This was portrayed by the 2011 movie
Puncture. Shaw's attempts to get his retractable needle accepted by health care facilities were covered in a 2010
Washington Monthly article.
Canada •
Health Canada Laboratory Biosafety Guidelines • Provincial Legislation: • British Columbia • Alberta • Manitoba • Saskatchewan • Ontario • Nova Scotia
Australia • No nationwide legislation is in place, but suggested practices or policies have been implemented in
New South Wales, Victoria, and Queensland. • New South Wales uses a set of guidelines called "Blood and Body Substances Occupational Exposure Prevention" which was revised in 2024. This guideline details best practices for prevention against needlestick injuries for those working in the healthcare field. It Was made in response to the "Worker Health and Safety Act of 2011" and the "Worker Health and Safety Regulation 2017". • Victoria uses a set of guidelines to provide instruction for workplace safety regarding needles and sharps. It elaborates on exposure protocols, evaluation and testing of the source, and management methods for immediate and follow-up actions to be taken. • Queensland has guidance for blood and body fluid exposure. This details chief responsibilities, first aid, risk assessment, testing, among other topics regarding bloodborne pathogen exposure and management. Unlike the guidance from the other states, Queensland has more information regarding neonatal and pediatric considerations.
Europe • The European Union has some regulations on this subject. One of these regulations is that of "Conformity Assessments". These are tests conducted by "Notified bodies" and approved by the EU to evaluate performance and safety of the product. Depending on the specific device used, it may be considered a "High Risk" device. If a device is deemed "High Risk", then an additional panel of experts will be needed in the approval process. == Sharps Containers ==